Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Outcomes of Rituximab for EBV Viremia/Post-Transplant Lymphoproliferative Disease in CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation

Kristen Poppiti, PharmD, Andrew Lin, PharmD, Nelly G. Adel, PharmD, BCOP, BCPS, Patrick Hilden, MS, Hugo Castro-Malaspina, MD

Blood (2016) 128 (22): 4623.

https://doi.org/10.1182/blood.V128.22.4623.4623

Published: 2016

Journal Articles

Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

Carmen Lau, PharmD, Valkal Bhatt, PharmD, Parastoo B. Dahi, MD, Sean Devlin, PhD, Yeon Yoo, BS, Nelly G. Adel, PharmD, BCOP, BCPS, Chris Mazis, Miguel Perales, MD, Sergio A. Giralt, MD, Guenther Koehne, MD PhD, Doris M Ponce, MD, Genovefa A Papanicolaou, MD, Juliet N. Barker, MBBS (Hons)

Blood (2016) 128 (22): 2219.

https://doi.org/10.1182/blood.V128.22.2219.2219

Published: 2016

Journal Articles

Incidence and Management of Proteasome Inhibitor-Related Cardiotoxicity in Multiple Myeloma Patients at Memorial Sloan Kettering Cancer Center

Josiah Land, PharmD, Salma Afifi, PharmD, BCOP, Nelly G. Adel, PharmD, BCOP, BCPS, Sean Devlin, PhD, Arshi Arora, MS, Nikoletta Lendvai, MD PhD, Ola Landgren, MD PhD

Blood (2015) 126 (23): 4265.

https://doi.org/10.1182/blood.V126.23.4265.4265

Published: 2015

Journal Articles

Effects of Obesity on the Efficacy and Toxicity of Induction Chemotherapy in Adult Acute Lymphoblastic Leukemia (ALL)

Tim J Peterson, PharmD, Andrew Lin, PharmD, BCOP, Patrick Hilden, MS, Sean Devlin, PhD, Nelly G. Adel, PharmD, BCOP, BCPS, Jae H Park, MD

Blood (2015) 126 (23): 1290.

https://doi.org/10.1182/blood.V126.23.1290.1290

Published: 2015

Journal Articles

Hypoalbuminemia Is Significantly Associated with Increased Clearance Time of High Doses of Methotrexate

Samantha N. Reiss, PharmD, Larry W. Buie, PharmD, BCOP, Nelly G. Adel, PharmD, BCOP, BCPS, Debra A. Goldman, MS, Sean Devlin, PhD, Dan Douer, MD

Blood (2015) 126 (23): 3711.

https://doi.org/10.1182/blood.V126.23.3711.3711

Published: 2015

Journal Articles

Analysis of VDT-PACE Utilization in Multiple Myeloma Patients Treated at MSKCC for Relapsed Disease or Cytoreduction and Stem Cell Mobilization after Initial Induction Therapy

Kristen Beyer, PharmD, BCOP, Samuel Rosner, Kaitlin M Woo, MA, Sean M. Devlin, PhD, Heather Landau, MD, Hani Hassoun, MD, Nikoletta Lendvai, MD PhD, David J Chung, MD PhD, Nelly G. Adel, PharmD, BCOP, BCPS, Marcin Puto, PharmD, BCOP, Ola Landgren, MD, PhD, Sergio Giralt, MD, Alexander M. Lesokhin, MD

Blood (2014) 124 (21): 3459.

https://doi.org/10.1182/blood.V124.21.3459.3459

Published: 2014

Journal Articles

Upfront Plerixafor Plus G-CSF Versus Cyclophosphamide Plus G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma Patients: An Update on Cost Analysis Study at Memorial Sloan Kettering Cancer Center

Salma Afifi, PharmD, Nelly G. Adel, PharmD, BCOP, BCPS, Elaine Duck, RN, MA, MS, Sean M. Devlin, PhD, Heather Landau, MD, Nikoletta Lendvai, MDPhD, Alexander M. Lesokhin, MD, David J. Chung, MD PhD, Ola Landgren, MD, PhD, Sergio A Giralt, MD, Hani Hassoun, MD

Blood (2014) 124 (21): 848.

https://doi.org/10.1182/blood.V124.21.848.848

Published: 2014

Journal Articles

Efficacy and Risk Factors Analysis of Upfront Autologous Stem Cell Mobilization Using Plerixafor and Granulocyte-Colony Stimulating Factor (GCSF) in Patients with Multiple Myeloma

Adebayo Ogunniyi, PharmD, MPA, Mabel Rodriguez, PharmD, BCOP, Sean M. Devlin, PhD, Nelly G. Adel, PharmD, BCOP, BCPS, Heather Landau, MD, David J Chung, MDPhD, Nikoletta Lendvai, MD PhD, Alexander M. Lesokhin, MD, Ola Landgren, MD PhD, Sergio A Giralt, MD, Hani Hassoun, MD

Blood (2014) 124 (21): 3856.

https://doi.org/10.1182/blood.V124.21.3856.3856

Published: 2014

Journal Articles

Similar Incidence of Typhlitis in Patients Receiving Various Doses of Daunorubicin or Idarubicin As Induction for Acute Myeloid Leukemia

Amanda N Seddon, PharmD, Angela G Michael, PharmD, BCOP, Nelly G. Adel, PharmD, BCOP, BCPS, Martin S. Tallman, MD, Oguz Akin, MD, Joshua Chaim, MD, Esther Drill, MS

Blood (2014) 124 (21): 3725.

https://doi.org/10.1182/blood.V124.21.3725.3725

Published: 2014

Journal Articles

Impact Of Renal Insufficiency and Obesity On Safety and Outcomes Of BEAM Conditioning

Salma Afifi, PharmD, Nelly G. Adel, PharmD, BCOP, BCPS, Zhigang Zhang, PhD, Weiji Shi, MS, Craig H. Moskowitz, MD, Matthew J. Matasar, MD, MS

Blood (2013) 122 (21): 3281.

https://doi.org/10.1182/blood.V122.21.3281.3281

Published: 2013

Journal Articles

High-Dose Cytarabine Monotherapy Versus Intermediate Or High-Dose Cytarabine In Combination With Other Agents As Second-Line Salvage Therapy In Patients With Acute Myeloid Leukemia Who Did Not Respond To Initial Induction Therapy

Thu Oanh T Dang, PharmD, BCOP, Patrick Hilden, MS, Sean M. Devlin, PhD, Raajit K. Rampal, M.D., Ph.D., Ross L. Levine, MD, Ellin Berman, MD, Virginia M. Klimek, M.D., Nelly G. Adel, PharmD, BCOP, BCPS, Martin S. Tallman, MD

Blood (2013) 122 (21): 2695.

https://doi.org/10.1182/blood.V122.21.2695.2695

Published: 2013

Journal Articles

Higher Mycophenolic Acid (MPA) Trough Levels Result In Lower Day 100 Severe Acute GVHD Without Increased Toxicity In Double-Unit Cord Blood Transplantation (CBT) Recipients

Stephen J. Harnicar, PharmD, BCOP, BCPS, Doris M Ponce, MD, David Gregornik, PharmD, Sherry Mathew, PharmD, BCOP, Katherine L Evans, BA, Junting Zheng, MS, Sean Devlin, PhD, Melissa Pozotrigo, PharmD, BCOP, Andromachi Scaradavou, MD, Nancy A. Kernan, MD, Nelly G. Adel, PharmD, BCOP, BCPS, Juliet N Barker, MBBS, (Hons), FRACP

Blood (2013) 122 (21): 3297.

https://doi.org/10.1182/blood.V122.21.3297.3297

Published: 2013

Journal Articles

Outcomes Of Tyrosine Kinase Inhibitors In Combination With Various Treatments Regimens In Adult Patients With Philadelphia Chromosome Positive Acute Lymphocytic Leukemia

Andrew Lin, PharmD, BCOP, Qin Zhou, Sean Devlin, PhD, Nelly G. Adel, PharmD, BCOP, BCPS, Dan Douer, MD

Blood (2013) 122 (21): 2644.

https://doi.org/10.1182/blood.V122.21.2644.2644

Published: 2013

Journal Articles

Cryotherapy Reduces Mucositis in Multiple Myeloma Patients Receiving High-Dose Melphalan Conditioning Prior to Autologous Stem Cell Transplantation

Mabel Rodriguez, PharmD, Nelly G. Adel, PharmD, BCOP, BCPS, Sean Devlin, PhD, Sergio A Giralt, MD, Heather Landau, MD

Blood (2012) 120 (21): 4265.

https://doi.org/10.1182/blood.V120.21.4265.4265

Published: 2012

Journal Articles

Administration of All-Trans Retinoic Acid (ATRA) to Newly Diagnosed Patients (pts) with Acute Promyelocytic Leukemia (APL) Is Delayed Even At Experienced Centers and Associated with An Increased Early Death Rate (EDR): A Retrospective Analysis of 205 Pts

Blood (2011) 118 (21): 942.

https://doi.org/10.1182/blood.V118.21.942.942

Published: 2011

Journal Articles

The Use of Combination PACE Regimens for Patients with Relapsed and Refractory Multiple Myeloma (MM) and Their Impact on Stem Cell Transplantation (SCT)

Marcin Puto, Pharm.D., Nelly G. Adel, PharmD, BCOP, BCPS, Hani Hassoun, MD, Sergio Giralt, MD, Heather Landau, MD

Blood (2011) 118 (21): 5127.

https://doi.org/10.1182/blood.V118.21.5127.5127

Published: 2011

Journal Articles

Cost Analysis of Using Plerixafor Plus G-CSF Versus Cyclophosphamide Plus G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma Patients Treated At Memorial Sloan-Kettering Cancer Center (MSKCC),

Nelly G. Adel, PharmD, BCOP, BCPS, Elaine Duck, RN, MA, MS, Karen Collum, RN, MSN, OCN, Emily Mccullagh, NP_C, Lilian Reich, MD, Heather Landau, MD, Sergio Giralt, MD, Hani Hassoun, MD

Blood (2011) 118 (21): 4059.

https://doi.org/10.1182/blood.V118.21.4059.4059

Published: 2011

NARROW

Outcomes of Rituximab for EBV Viremia/Post-Transplant Lymphoproliferative Disease in CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation

Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

Incidence and Management of Proteasome Inhibitor-Related Cardiotoxicity in Multiple Myeloma Patients at Memorial Sloan Kettering Cancer Center

Effects of Obesity on the Efficacy and Toxicity of Induction Chemotherapy in Adult Acute Lymphoblastic Leukemia (ALL)

Hypoalbuminemia Is Significantly Associated with Increased Clearance Time of High Doses of Methotrexate

Analysis of VDT-PACE Utilization in Multiple Myeloma Patients Treated at MSKCC for Relapsed Disease or Cytoreduction and Stem Cell Mobilization after Initial Induction Therapy

Upfront Plerixafor Plus G-CSF Versus Cyclophosphamide Plus G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma Patients: An Update on Cost Analysis Study at Memorial Sloan Kettering Cancer Center

Efficacy and Risk Factors Analysis of Upfront Autologous Stem Cell Mobilization Using Plerixafor and Granulocyte-Colony Stimulating Factor (GCSF) in Patients with Multiple Myeloma

Similar Incidence of Typhlitis in Patients Receiving Various Doses of Daunorubicin or Idarubicin As Induction for Acute Myeloid Leukemia

Impact Of Renal Insufficiency and Obesity On Safety and Outcomes Of BEAM Conditioning

High-Dose Cytarabine Monotherapy Versus Intermediate Or High-Dose Cytarabine In Combination With Other Agents As Second-Line Salvage Therapy In Patients With Acute Myeloid Leukemia Who Did Not Respond To Initial Induction Therapy

Higher Mycophenolic Acid (MPA) Trough Levels Result In Lower Day 100 Severe Acute GVHD Without Increased Toxicity In Double-Unit Cord Blood Transplantation (CBT) Recipients

Outcomes Of Tyrosine Kinase Inhibitors In Combination With Various Treatments Regimens In Adult Patients With Philadelphia Chromosome Positive Acute Lymphocytic Leukemia

Cryotherapy Reduces Mucositis in Multiple Myeloma Patients Receiving High-Dose Melphalan Conditioning Prior to Autologous Stem Cell Transplantation

Administration of All-Trans Retinoic Acid (ATRA) to Newly Diagnosed Patients (pts) with Acute Promyelocytic Leukemia (APL) Is Delayed Even At Experienced Centers and Associated with An Increased Early Death Rate (EDR): A Retrospective Analysis of 205 Pts

The Use of Combination PACE Regimens for Patients with Relapsed and Refractory Multiple Myeloma (MM) and Their Impact on Stem Cell Transplantation (SCT)

Cost Analysis of Using Plerixafor Plus G-CSF Versus Cyclophosphamide Plus G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma Patients Treated At Memorial Sloan-Kettering Cancer Center (MSKCC),

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only